...
首页> 外文期刊>Archives of Biochemistry and Biophysics >Chlorogenic acid analogue S 3483: A potent competitive inhibitor of the hepatic and renal glucose-6-phosphatase systems
【24h】

Chlorogenic acid analogue S 3483: A potent competitive inhibitor of the hepatic and renal glucose-6-phosphatase systems

机译:绿原酸类似物S 3483:肝和肾葡萄糖6磷酸酶系统的有效竞争性抑制剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

S 3483, a synthetic derivative of chlorogenic acid (CHL), was found to be a reversible, linear competitive inhibitor of the glucose-6-phosphatase (Glc-6-Pase) system in rat renal microsomes and rat and human liver microsomes, The Ri for S 3483 in rat liver microsomes (129 nM) is three orders of magnitude smaller than the K-i for CHL. S 3483 up to 100 mu M had no effect on the Glc-8-Pase enzyme activity or on the system inorganic pyrophosphatase activity (i.e., on T2, the P-i/inorganic pyrophosphate transporter), Thus, like CHL, S 3483 appears to be a site-specific inhibitor of T1, the Glc-6-P transporter of renal and liver microsomes, The potency of S 3483 was unaffected when the ratio V-max(T1):V-max(enzyme) was altered over a 10-fold range by applying enzyme inhibition and selective inactivation of T1, The absence of T1-imposed rate restrictions on the potency of reversible T1 inhibitors contrasts markedly with the response of reversible Glc-6-Pase enzyme inhibitors, whose potency declines sharply as T1 becomes more rate controlling, The potency of S 3483, but not of CHL, decreased as the microsomal protein concentration in the assay medium was increased, This effect suggests that as the protein concentration was raised the concentration of T1 in the assay medium approached the order of magnitude of the K-i for S 3483, Thus, the microsomal content of T1 is likely to be on the order of 100 pmol/mg protein, S 3483 is the most potent inhibitor of the Glc-6-Pase system reported to date, It and other tight-binding inhibitors of T1 will provide useful new tools for investigating the molecular structure and physiology/pathology of the Glc-6-Pase system. (C) 1998 Academic Press. [References: 30]
机译:S 3483是绿原酸(CHL)的合成衍生物,是大鼠肾微粒体以及大鼠和人肝微粒体中葡萄糖6磷酸酶(Glc-6-Pase)系统的可逆线性竞争抑制剂。大鼠肝微粒体中S 3483的Ri(129 nM)比CHL的Ki小3个数量级。高达100μM的S 3483对Glc-8-Pase酶活性或系统的无机焦磷酸酶活性(即对T2的Pi /无机焦磷酸转运蛋白)没有影响,因此,像CHL一样,S 3483似乎是T1的位点特异性抑制剂,肾和肝微粒体的Glc-6-P转运蛋白,当V-max(T1):V-max(酶)的比例在10-V范围内改变时,S 3483的效力不受影响。通过对酶的抑制和对T1的选择性失活来实现倍数范围的变化,而对可逆T1抑制剂的效力没有T1施加的速率限制则与可逆Glc-6-Pase酶抑制剂的响应形成鲜明对比,后者随着T1的增加而效力急剧下降速率控制,随着测定培养基中微粒体蛋白质浓度的增加,S 3483的效力(而不是CHL的效力)降低。此效果表明,随着蛋白质浓度的增加,测定培养基中T1的浓度接近数量级S的Ki 3483,因此,T1的微粒体含量可能约为100 pmol / mg蛋白,S 3483是迄今为止报道的最强力的Glc-6-Pase系统抑制剂,它和其他紧密结合的抑制剂T1将为研究Glc-6-Pase系统的分子结构和生理学/病理学提供有用的新工具。 (C)1998年学术出版社。 [参考:30]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号